Adoption of new medicines in primary care: a comparison between the uptake of new oral anticoagulants and diabetes medicines.

Marloes DankersK HekA K Mantel-TeeuwisseL Van DijkH J M G Nelissen-Vrancken

Published in: British journal of clinical pharmacology (2023)

DOACs and incretin based therapies have different adoption profiles and practice variation is large, especially in the years before these medicines were introduced in guidelines. Early adopters of both medicine classes differ.

Keyphrases

primary care
oral anticoagulants
atrial fibrillation
electronic health record
type diabetes
cardiovascular disease
healthcare
clinical practice
general practice
glycemic control
direct oral anticoagulants
quality improvement
metabolic syndrome
venous thromboembolism